AI cybersecurity is a cat and mouse gamejust now Google Research Releases ToolGrad: Answer-First Framework Hits 99.8% Pass Rate for Tool-Use Data Generation1h ago China's star AI labs routed user requests to Claude at least 35 million times in the summer: Anthropic1h ago Anthropic and OpenAI employees speak out about humanity’s extinction as debate reaches fever pitch1h ago Force launches chatbot for non-emergency calls1h ago Tesla unveils driverless Cybercab in Japan for 1st time2h ago How Maersk Is Using AI To Survive The New Era Of Tariff Chaos2h ago Russia to require content made by, with AI to be labeled as such — GFCN president3h ago Flipkart’s Super.money Bets on AI Agents to Outdo Bigger Rivals4h ago Datasette 1.0a39 and 0.65.4 security releases4h ago Anthropic caught scientists using Claude to further biological weapon research4h ago Oracle says AI will save it from the SaaSpocalypse, not bring it on4h ago Congress Is Suddenly Waking Up to the AI Doomsday Threat5h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself5h ago

AI cybersecurity is a cat and mouse gamejust now Google Research Releases ToolGrad: Answer-First Framework Hits 99.8% Pass Rate for Tool-Use Data Generation1h ago China's star AI labs routed user requests to Claude at least 35 million times in the summer: Anthropic1h ago Anthropic and OpenAI employees speak out about humanity’s extinction as debate reaches fever pitch1h ago Force launches chatbot for non-emergency calls1h ago Tesla unveils driverless Cybercab in Japan for 1st time2h ago How Maersk Is Using AI To Survive The New Era Of Tariff Chaos2h ago Russia to require content made by, with AI to be labeled as such — GFCN president3h ago Flipkart’s Super.money Bets on AI Agents to Outdo Bigger Rivals4h ago Datasette 1.0a39 and 0.65.4 security releases4h ago Anthropic caught scientists using Claude to further biological weapon research4h ago Oracle says AI will save it from the SaaSpocalypse, not bring it on4h ago Congress Is Suddenly Waking Up to the AI Doomsday Threat5h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself5h ago

Laigo Bio closes €17M seed to advance SureTACs

The Next WebPublished Mar 27, 2026

Laigo Bio has secured €17 million in seed funding to develop its SureTACs technology, aiming to advance targeted cancer therapies. The investment will support preclinical development and preparation for clinical trials.

#laigo-bio #seed-funding #suretacs #targeted-cancer-therapy

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes12h ago

Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch10h ago

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources1d ago